OKYO Pharma Announces Positive Data in Long-Term Stability of Urcosimod
Urcosimod in Phase 2 clinical trial for Neuropathic Corneal Pain shown to have Long-Term StabilityUrcosimod stable in single-use ampoules for ...
Ophthalmology Times5 天
OKYO Pharma releases positive long-term stability data for urcosimod in neuropathic corneal ...
Urcosimod (formerly known as OK-101) has been shown to be stable for over 2 and a half years in single-use ampoules used for ...
Okyo Pharma announces data on long-term stability of urcosimod
OKYO Pharma (OKYO) announced that the Company has established that urcosimod has been shown to be stable for over two and a half years in ...